Basecare Medical to Acquire BMX Holdco for $40 Million, Expanding IVF Portfolio

China-based in vitro fertilization (IVF) specialist, Suzhou Basecare Medical Co., Ltd (HKG: 2170), has announced its intention to acquire 100% stakes in Singapore-headquartered BMX Holdco Pte. Ltd for a sum of $40 million. The acquisition will see BMX becoming a wholly-owned subsidiary of Basecare upon deal closure.

BMX Holdco Pte. Ltd: A Leader in IVF Automation and Workflow Standardization
BMX is a leading fertility product supplier that specializes in the automation and standardization of workflow in IVF laboratories. The company has developed innovative products such as the time difference incubator and automatic vitrification freezing instrument. With a global business presence spanning multiple countries, BMX reported sales of RMB91.2 million for the last year, marking a 13% increase year-on-year.

Basecare Medical Co., Ltd: A Comprehensive IVF Solution Provider
Basecare, on the other hand, is known for its comprehensive range of solutions in the IVF sector, including PGT laboratory, andrology laboratory, cryostorage laboratory, embryo laboratory, and software laboratory. The company’s acquisition of BMX is expected to strengthen its position in the global IVF market and enhance its service offerings.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry